Richiedi una copia del documento: Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome : A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial)

Captcha code
Annulla